The head of the EU drug regulator’s Covid-19 task force said on Sunday that AstraZeneca’s coronavirus vaccine had a favourable risk-benefit profile for all age groups and particularly for those aged over 60. Italian newspaper La Stampa earlier quoted European Medicines Agency (EMA) task force chief Marco Cavaleri as saying countries should avoid giving the vaccine to people aged over.
MILAN, June 14 The head of the EU drug regulator’s COVID-19 task force said on Sunday that AstraZeneca’s coronavirus vaccine had a favourable risk-benefit profile for all age groups and particularly for those aged over 60. Italian newspaper La Stampa earlier quoted European Medicines Agency.
Astra-Zeneca COVID jab has favourable risk-beneft profile nationnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nationnews.com Daily Mail and Mail on Sunday newspapers.